The generic equivalent of Merck’s Maxalt tablets, Rizatriptan Benzoate, indicated for the acute treatment of migraine has just been approved by the Federal Drug Administration. India based Aurobindo Pharma has received final approval to manufacture and market Rizatriptan 5mg and 10mg tablets. The company says they are ready to launch the medication….. Express Pharma 1/2/13
Subscribe To Our Weekly Newsletter
You have Successfully Subscribed!
Archives
Top Posts
- "What Can Cause Stomach Pain and a Headache?" from Medical News Today
- CGRP QUESTIONS/ANSWERS
- New Butalbital Product(similar to Fioricet/Fiorinal/Esgic/Phrenilin)
- Turmeric (Curcumin) Capsules for Headaches and Arthritis Migraine blog
- CGRP AND SIDE EFFECTS: LETTER IN ‘HEADACHE”
- "The Secret Power Of The 8-Minute Phone Call" from The New York Times
- "Lingering Effects of COVID-19: The Migraine That Just Won't Go Away" from ABC 10
- Risks Associated with Multivitamins and Vitamin Supplements
Topics
adolescents
Alzheimer's disease
Alzheimers
anxiety
back pain
blood pressure
botox
brain
caffeine
children
chronic migraine
chronic pain
cluster headache
concussion
concussions
COVID-19
dementia
depression
diet
exercise
fibromyalgia
Headache
headache blog
headaches
health
heart disease
meditation
migraine
migraine headache
migraine headaches
migraines
migraine triggers
migraine with aura
pain
Pandemic
physical activity
sleep
stress
stroke
triggers
triptans
vitamin D
walking
women
yoga